qEEG Brain Signature of Depression & Neuromodulation-induced Recovery
Recruiting
Phase 1
Interventional Study
Major Depressive Diorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Sunnybrook Health Sciences Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to explore how repetitive transcranial magnetic stimulation (rTMS), a treatment for depression, affects brain function. Depression disrupts the brain's complex network or regions that regulate cognition, emotion, and behavior. rTMS targets these disruptions to restore network function. To measure these effects, researchers will use dry quantitative EEG (qEEG), a new technology that…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* A diagnosis of Depression based on Diagnostic and Statistical Manual (DSM) 5.0 criteria.
* Receiving a neuromodulation (rTMS) treatment for depression at the HCN
* Physically healthy
* Age 18-80, inclusive.
* Able to provide informed consent and comply with the study protocol.…
Contacts